Sign In

Dr. Daniel Rifkin, MD, MPH

Chief Executive Officer at Ognomy – The Sleep Apnea App

Dr. Daniel Rifkin, MD, MPH is a prominent figure in the field of sleep medicine and healthcare innovation. He is the founder and Chief Executive Officer of Ognomy, a groundbreaking healthcare service that has revolutionized the diagnosis and treatment of sleep apnea.13

Professional Background

Dr. Rifkin is a board-certified neurologist with over two decades of experience in sleep medicine.1 His career highlights include:

  • Founder and CEO of Ognomy: Launched in February 2021, Ognomy is the first healthcare service to fully transition sleep apnea diagnosis and care from clinical settings to patients' homes.12

  • Founder and Medical Director: Established the Sleep Medicine Centers of Western New York in 2002, providing care for various sleep disorders.1

  • Academic Role: Serves as a clinical assistant professor of neurology at the University at Buffalo, where he teaches and conducts clinical research.1

Education

Dr. Rifkin's educational background is comprehensive:

  • Doctor of Medicine (M.D.) from the Geisel School of Medicine at Dartmouth2
  • Master of Public Health (MPH) in Global Health from The George Washington University2
  • Bachelor's Degree from Hamilton College2

Innovation in Sleep Medicine

Under Dr. Rifkin's leadership, Ognomy has transformed sleep apnea care:

  1. Home-based Diagnosis: Utilizes FDA-approved home sleep tests instead of relying solely on in-laboratory testing.3

  2. Data-driven Improvements: Implements an analytics layer to enhance patient experience and make UX improvements.3

  3. Expanded Platform: Developed Ognomy into an end-to-end platform, enabling home health companies to offer virtual care and serving as a SaaS product for physicians nationwide.3

Dr. Rifkin's innovative approach has positioned Ognomy at the forefront of sleep medicine technology, continuously exploring new ways to improve patient care and treatment accessibility.3

Highlights

May 16 · linkedin

I’m often asked why I decided to forgo my training in neurology and instead focus my career on #sleep medicine. Simply, watch this video and you’ll understand my choice.

On a weekly, if not daily, basis I’m privileged to hear about the positive impact we’ve made on patients’ lives. It’s truly the fuel that feeds a fire in my belly to address #sleepapnea as a global health concern. Thank you Chris, and to countless patients, for sharing your story so others can learn about the importance of treating this pervasive sleep disorder that affects over a billion people worldwide.

Join us in our fight to save the night!

#thankyou #health #sleephealth Ognomy Sleep

Nov 18 · linkedin

I am absolutely thrilled to say Ognomy has been nominated as a finalist in the Upstate Capital Association of New York's Annual Awards Celebration this year. It is an honor to be listed and recognized by those in the investment community and for Ognomy to be continually supported in our mission to help one billion people worldwide who suffer needlessly from #sleepapnea.

Best of luck to all of the nominees, and I look forward to meeting and celebrating with you all on December 7 in Rochester!

➡️ bit.ly/3Og3kF5

#impactinvesting #sleepmedicine #sleephealth #telemedicine #seedfunding #entrepreneurs #innovation

Related Questions

What inspired Dr. Rifkin to shift sleep apnea diagnosis from clinical settings to home?
What are the key features of Ognomy's home sleep tests?
How has Ognomy's approach to sleep apnea diagnosis impacted patient outcomes?
What are the future plans for Ognomy's expansion?
How does Ognomy's platform integrate with home health companies?
Dr. Daniel Rifkin, MD, MPH
Dr. Daniel Rifkin, MD, MPH, photo 1
Dr. Daniel Rifkin, MD, MPH, photo 2
Add to my network

Location

Buffalo, New York, United States